Neutralization Of Inhibitory Pathways In Lymphocytes

Patent No. EP3405495 (titled "Neutralization Of Inhibitory Pathways In Lymphocytes") was filed by Innate Pharma on Jan 20, 2017. The application was issued on Feb 24, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOIBERG PSNov 24, 2021ZWICKER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3405495

INNATE PHARMA
Application Number
EP17702315A
Filing Date
Jan 20, 2017
Status
Granted And Under Opposition
Jan 22, 2021
Publication Date
Feb 24, 2021